REGN.NASDAQRegeneron Pharmaceuticals, INC
13F-HR: Regeneron Pharmaceuticals 13F Holdings — June 30, 2026
Institutional Holdings Report (13F)
Regeneron Pharmaceuticals, Inc. reported 3 holdings worth $177.2M for the period ended June 30, 2026.
Summary
- Regeneron Pharmaceuticals, Inc. reported 3 holdings worth $177.2M as of June 30, 2026.
- Parabilis Medicines, Inc. — $114.0M (64.35%), 4,166,666 SH.
- Intellia Therapeutics, Inc. — $62.7M (35.35%), 3,702,995 SH.
- Adicet Bio, Inc. — $522.8K (0.3%), 60,511 SH.
Top Holdings
Regeneron Pharmaceuticals, Inc. · 3 positions · $177.2M total · as of June 30, 2026
| Issuer | Value | % Port. | Shares |
|---|---|---|---|
| Parabilis Medicines, Inc. | $114.0M | 64.35% | 4,166,666 |
| Intellia Therapeutics, Inc. | $62.7M | 35.35% | 3,702,995 |
| Adicet Bio, Inc. | $522.8K | 0.3% | 60,511 |
Keywords
13F, institutional holdings, Regeneron Pharmaceuticals, Inc., Parabilis Medicines, Inc., Intellia Therapeutics, Inc., Adicet Bio, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.